To further assess the role of T-cell activation in disease severity of HL, we analyzed CD3+CD4+HLA-DR+ and CD3+CD8+HLA-DR+ T cells in two risk classification groups. The gene discussed is CD4; the disease is Hodgkins lymphoma.